Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Novo Nordisk claims xanomeline as potential urinary bladder disorder treatment

July 26, 1996

Positive results in trial of Cystistat in refractory interstitial cystitis patients

July 19, 1996

CGP-53153: Ciba-Geigy's steroidal 5alpha-reductase inhibitor as BPH therapy

July 19, 1996

Glaxo Wellcome describes alpha1A-adrenoceptor antagonists

July 19, 1996

Cystistat covered under U.S. patent

July 12, 1996

5alpha-Reductase inhibitors from Kyowa Hakko

July 12, 1996

Selective alpha1A-adrenoceptor antagonists with multiple indications

July 12, 1996

Flutamide BPH trial results reported

July 5, 1996

Abbott reports alpha1-antagonists for BPH

July 5, 1996

Human Genome Sciences discloses polypeptide research

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...